Gastroenteropancreatic Neuroendocrine Tumors: Personalized Diagnostic and Therapeutic Strategies for Optimized Outcomes

Register Now
Dates
  • Tuesday, October 28, 2025
  • Thursday, October 30, 2025
 
Time
12:00 PM (UTC-04:00) Eastern Time (US & Canada)
 
Duration
60 minutes
 
Credit Type
CME, AAPA, CNE, AANP, CPE
 
Intended Learners

This activity is intended for community oncology healthcare professionals (HCPs) who care for patients with GEP-NETs, including oncologists, and advanced oncology providers (APPs)

 
Learning Objectives
  • Identify therapeutic challenges and unmet needs associated with the clinical management of GEP-NETs 
  • Evaluate the efficacy and safety of current and emerging treatment strategies across GEP-NET subtypes
  • Apply tumor-specific factors—such as grade, differentiation, and functional status—to select and implement evidence-based diagnostic and treatment algorithms tailored to individual GEP-NET clinical scenarios
 
Continuing Education
 
Jointly Accredited Provider
 

In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Note: This statement is not an indication of approved credits. Please visit https://hmpeducation.com/program/25-onccme-303 for full accreditation details, including credit types and totals, for this activity.

Supported by educational grants from Novartis Pharmaceuticals Corporation and Exelixis, Inc.

 

Speakers

Jonathon Strosberg, MD
Jonathon Strosberg, MD
Medical Director, Clinical Research
Moffitt Cancer Center
Nitya Raj, MD
Nitya Raj, MD
Assistant Attending Physician, Department of Medicine
Memorial Sloan Kettering Cancer Center